Cargando…
Recent Developments in Recombinant Protein–Based Dengue Vaccines
Recombinant proteins are gaining enormous importance these days due to their wide application as biopharmaceutical products and proven safety record. Various recombinant proteins of therapeutic and prophylactic importance have been successfully produced in microbial and higher expression host system...
Autores principales: | Tripathi, Nagesh K., Shrivastava, Ambuj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115509/ https://www.ncbi.nlm.nih.gov/pubmed/30190720 http://dx.doi.org/10.3389/fimmu.2018.01919 |
Ejemplares similares
-
Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development
por: Tripathi, Nagesh K., et al.
Publicado: (2019) -
Evaluation of antibody response against recombinant domain III proteins of dengue virus type 1 and 2
por: Tripathi, Nagesh K, et al.
Publicado: (2017) -
Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
por: Carascal, Mark B., et al.
Publicado: (2022) -
Corrigendum: Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
por: Carascal, Mark B., et al.
Publicado: (2022) -
Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice
por: Hou, Jue, et al.
Publicado: (2019)